214866727 | PUO | 60483792 | | 5750040 | 7/24/2005 12:00:00 AM | heart failure , mitral regurgitation | | DIS | Admission Date: 11/12/2005 Report Status: Discharge Date: 7/16/2005 ****** DISCHARGE ORDERS ****** SLITER , ELKE HUNTER 112-91-28-5 Ette Service: CAR DISCHARGE PATIENT ON: 11/4/05 AT 02:00 PM CONTINGENT UPON HO evaluation WILL D/C ORDER BE USED AS THE D/C SUMMARY: YES Attending: ROBBLEE , NERISSA H. , M.D. , PH.D. CODE STATUS: Full code DISPOSITION: Home DISCHARGE MEDICATIONS: VITAMIN C ( ASCORBIC ACID ) 500 MG PO QD ECASA ( ASPIRIN ENTERIC COATED ) 81 MG PO QD Alert overridden: Override added on 10/22/05 by BENCH , MACIE G. , M.D. POTENTIALLY SERIOUS INTERACTION: WARFARIN &amp; ASPIRIN Reason for override: tolerates VITAMIN E ( TOCOPHEROL-DL-ALPHA ) 400 UNITS PO QD BISOPROLOL FUMARATE 10 MG PO BID Food/Drug Interaction Instruction Take consistently with meals or on empty stomach. 
Override Notice: Override added on 10/22/05 by BENCH , MACIE G. , M.D. on order for TIAZAC PO ( ref # 74555903 ) POTENTIALLY SERIOUS INTERACTION: BISOPROLOL FUMARATE &amp; DILTIAZEM HCL Reason for override: tolerates Number of Doses Required ( approximate ): 4 DOFETILIDE 500 MCG PO BID Starting IN AM ( 9/20 ) Override Notice: Override added on 10/22/05 by BENCH , MACIE G. , M.D. on order for METFORMIN PO ( ref # 81144492 ) POTENTIALLY SERIOUS INTERACTION: DOFETILIDE &amp; METFORMIN HCL Reason for override: tolerates Previous override information: Override added on 10/22/05 by BENCH , MACIE G. , M.D. POTENTIALLY SERIOUS INTERACTION: METFORMIN HCL &amp; DOFETILIDE POTENTIALLY SERIOUS INTERACTION: METFORMIN HCL &amp; DOFETILIDE Reason for override: tolerates , monitoring COUMADIN ( WARFARIN SODIUM ) 10 MG PO QPM Starting ROUTINE , 20:00 ( Standard Admin Time ) ( 9/20 ) Food/Drug Interaction Instruction No high Vitamin-K containing foods Alert overridden: Override added on 10/22/05 by : POTENTIALLY SERIOUS INTERACTION: SIMVASTATIN &amp; WARFARIN POTENTIALLY SERIOUS INTERACTION: ASPIRIN &amp; WARFARIN Reason for override: will monitor COUMADIN ( WARFARIN SODIUM ) 12 MG PO QPM Starting ROUTINE , 20:00 ( Standard Admin Time ) ( 9/20 ) Instructions: on Friday , Monday Food/Drug Interaction Instruction No high Vitamin-K containing foods Alert overridden: Override added on 10/22/05 by : POTENTIALLY SERIOUS INTERACTION: SIMVASTATIN &amp; WARFARIN POTENTIALLY SERIOUS INTERACTION: ASPIRIN &amp; WARFARIN Reason for override: will monitor LIPITOR ( ATORVASTATIN ) 40 MG PO QD Alert overridden: Override added on 10/22/05 by : POTENTIALLY SERIOUS INTERACTION: WARFARIN &amp; ATORVASTATIN CALCIUM POTENTIALLY SERIOUS INTERACTION: WARFARIN &amp; ATORVASTATIN CALCIUM POTENTIALLY SERIOUS INTERACTION: WARFARIN &amp; ATORVASTATIN CALCIUM Reason for override: tolerates , monitored GLUCOVANCE ( GLYBURIDE/METFORMIN ) 2.5/500 MG PO BID Instructions: Take 1.5 pills in morning and 2 pills in evening as you have been doing Alert overridden: Override added on 10/22/05 by : POTENTIALLY SERIOUS INTERACTION: DOFETILIDE &amp; METFORMIN HCL POTENTIALLY SERIOUS INTERACTION: DOFETILIDE &amp; METFORMIN HCL Reason for override: tolerates , monitored DILTIAZEM CD 120 MG PO QD Food/Drug Interaction Instruction Avoid grapefruit unless MD instructs otherwise. 
Alert overridden: Override added on 10/22/05 by : POTENTIALLY SERIOUS INTERACTION: BISOPROLOL FUMARATE &amp; DILTIAZEM HCL Reason for override: tolerates , monitored LASIX ( FUROSEMIDE ) 40 MG PO QD DIET: House / Low chol/low sat. 
fat ACTIVITY: Resume regular exercise FOLLOW UP APPOINTMENT( S ): Dr. Prewer , call for appointment within 1 week , Arrange INR to be drawn on 5/5/05 with f/u INR's to be drawn every 30 days. 
INR's will be followed by anticogulation clinic 254-1706 ALLERGY: LISINOPRIL , Codeine , PROCAINAMIDE ADMIT DIAGNOSIS: mitral regurgitation PRINCIPAL DISCHARGE DIAGNOSIS ;Responsible After Study for Causing Admission ) heart failure , mitral regurgitation OTHER DIAGNOSIS;Conditions , Infections , Complications , affecting Treatment/Stay HYPERCHOLESTEROLEMIA PAF RF REFLUX ESOPHAGITIS OPERATIONS AND PROCEDURES: OTHER TREATMENTS/PROCEDURES ( NOT IN O.R. ) Diuresis BRIEF RESUME OF HOSPITAL COURSE: CC: 56 yo woman with MR , PAF , admitted with SOB , orthopnea , PND. HPI: Pt was in USOH until 5 d PTA when she went into atrial fibrillation. 
She has a long history of PAF and during her episodes tends to feel very poorly with fatigue , palpitations , DOE. 
She was cardioverted back to NSR the day prior to admission , and went home feeling well. 
Overnight , however , she awoke with PND , orthopnea , cough , and audible wheeze. 
She reports never having had a similar episode in the past , though she does note that she has been having some increasing exertional dyspnea over the last few months. 
No chest pain , N/V , diaphoresis. 
She has never had peripheral edema. 
She presented to PUO ED after discussion with her cardiologist Dr. Denisha Mcrorie In the ED , vitals stable with HR 70s-80s and BP 133/64. 
SaO2 96-98% on RA. Pt was admitted. 
PMH: MR ( mod on echo 2002 ) secondary to rheumatic heart dz as child. 
Nl LV fxn echo 2002. 
PAF , s/p multiple cardioversions. 
On coumadin. 
DM , hypercholesterolemia , endocarditis 1967 , TAH/BSO , hx procainamide-induced SLE. 
MEDS:Glucovance 1.5 q am , 2 qpm. 
Bisoprolol10 bid. 
Coumadin 6/24 M and F. Dofetilide .5 bid. 
lipitor 40. 
Dilt CR 120qd. 
ASA 81. Garlic , Vit C , Vit D. SH: tob quit age 20 , no etoh. 
She is a minister in non-denominational church. 
PE: obese , pleasant woman in NAD. 
Notable for MR murmur apex--&gt;axilla. 
Lungs clear. 
JVP at angle of jaw. 
DP pulses palpable. 
LABS: Notable for INR 3.8 , BNP 311. 
EKG: NSR , LAE. CXR: enlarged heart , sm L effusion. 
?increased 
vascular prominence. 
ECHO: Day PTA , final report pending , by verbal report shows severe MR ( moderate on past studies ). 
ASSESSMENT: 56 yo woman with MR and PAF admitted with symptoms of heart failue most likely related to chronic worsening MR. HOSPITAL COURSE: **CV: I: No evidence ichemia , no known CAD. 
Continued on ASA , statin. 
P: MR secondary to RHD. 
Current sx heart failure likely related to worsening MR. 
Ms. Sliter responded very well to diuresis with improvement in her dyspnea , orthopnea , cough and wheeze. 
She was discharged on a standing dose 40 po lasix qd and was instructed to follow up with Dr. Prewer for discussion of future management options including MVR R: PAF , NSR at present. 
Her weight 4/25 is 114kg. 
She was continued on her home anti-arrhythmic regimen as well as on coumadin. 
coumadin held for elevated INR 1/1 **ENDOCRINE: DM Type II. 
Home regimen held in favor of lantus basal insulin and novolog ss for tighter glycemic control in-house. 
Pt was restarted on home regimen at discharge. 
**FEN: 2 gm Na , carbohydrate controlled. 
**PPX: on coumadin **CODE:FULL ADDITIONAL COMMENTS: 1. Resume all your normal home medications at the doses you were taking. 
2. Your new medication is lasix , which helps remove excess fluid from the body. 
Have your blood chemistries checked ( potassium , magnesium ) 3. Make an appointment to see Dr. Prewer within one week. 
4. Ask Dr. Remley to check your EKG on dofetilide to make sure that your "QTc" ( heart function ) is not long due to metformin + dofetilide 5. Your sugars have been mildly elevated ( 190s ). 
Have your sugars checked as meds adjusted as an outpt DISCHARGE CONDITION: Stable TO DO/PLAN: 1. follow up ECHO - Dr. Prewer will compare in-patient ECHO and priors to determine interval change in valve function , ?when to undergo repair vs. replacement 2. optimize medical regimen for management of mitral regurgitation , lasix + consider hydral + nitrates for afterload reduction ( pt was told she had ?'lupus like' symptoms on lisinopril ). 
ACE-I would be best if she can tolerate this No dictated summary ENTERED BY: CLARDY , CHRISTY ALVINA , M.D. ( BL29 ) 11/4/05 @ 02 ****** END OF DISCHARGE ORDERS ******